Peter P. Pfreundschuh's Net Worth
$2.55 Million
Who is Peter P. Pfreundschuh?
Peter P. Pfreundschuh has an estimated net worth of $2.55 Million. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, Sucampo Pharmaceuticals, Inc., UroGen Pharma Ltd., Frequency Therapeutics, Inc., Voyager Therapeutics, Inc., and Y-mAbs Therapeutics, Inc..
SEC CIK
Peter P. Pfreundschuh's CIK is 0001585839
Past Insider Trading and Trends
2020 was Peter P. Pfreundschuh's most active year for acquiring shares with 10 total transactions. Peter P. Pfreundschuh's most active month to acquire stocks was the month of January. 2020 was Peter P. Pfreundschuh's most active year for disposing of shares, totalling 18 transactions. Peter P. Pfreundschuh's most active month to dispose stocks was the month of January. 2017 saw Peter P. Pfreundschuh paying a total of $3,585.40 for 150,394 shares, this is the most they've acquired in one year. In 2018 Peter P. Pfreundschuh cashed out on 150,263 shares for a total of $1,069,734.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNOMEDICS INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +106.79% | 15.34K |
—
|
—
| 29.71K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
∞
| 15.81K |
—
|
—
| 15.81K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sucampo Pharmaceuticals, Inc. No price found
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -263.00 |
$18.00 | -$4,734.00 |
0
|
Feb 13
| |||
Form 4
|
∞
| 394 |
$9.10 | $3,585.40 | 394 |
Sep 30 - Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
UroGen Pharma Ltd. (URGN) Snapshot price: $13.23
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.91% | 2.52K |
$21.77 | -$52,247.75 | 10.4K |
Oct 15
| |||
Form 4
| +7.25% | 533 |
$22.82 | -$11,615.38 | 7.89K |
Sep 1
| |||
Form 4
| +3.90% | 276 |
$23.51 | -$3,314.91 | 7.36K |
Jul 26 - Jul 27
| |||
Form 4
| +10.68% | 683 |
$25.07 | -$8,975.06 | 7.08K |
May 20
| |||
Form 4
| +4.51% | 276 |
$24.35 | -$3,433.35 | 6.4K |
Apr 26 - Apr 27
| |||
Form 4
| +12.54% | 682 |
$29.68 | -$10,684.80 | 6.12K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +29.05% | 1K |
$29.28 | -$19,529.76 | 4.44K |
Jan 26 - Jan 27
| |||
Form 4
| +25.01% | 688 |
$28.41 | -$10,057.14 | 3.44K |
Nov 20
| |||
Form 4
|
∞
| 2.75K |
$33.07 | -$46,827.12 | 2.75K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Frequency Therapeutics, Inc. (KRRO) Snapshot price: $42.73
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.81% | -2.95K |
$3.69 | -$10,885.03 | 8.93K |
Feb 18 - Feb 22
| |||
Form 4
| -17.54% | -2.52K |
$4.31 | -$10,886.44 | 11.87K |
Feb 16 - Feb 17
| |||
Form 4
| +1,832.62% | 13.65K |
$4.33 | -$5,833.86 | 14.4K |
Feb 14 - Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.10% | -3.76K |
$7.46 | -$28,079.44 | 175.67K |
Feb 21
| |||
Form 4
| +20.08% | 30K |
—
|
—
| 179.43K |
Feb 9
| |||
Form 4
| -8.32% | -13.57K |
$6.99 | -$94,833.33 | 149.43K |
Oct 3
| |||
Form 4
| +30.40% | 38K |
—
|
—
| 163K |
Feb 17
| |||
Form 4
|
∞
| 125K |
—
|
—
| 125K |
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||